In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
A new life sciences investment company, which includes former senior pharma industry executive, has commenced operations with initial funding from institutional investors. 22 February 2016
Pharmaceutical
Therapeutic Proteins International (TPI) has announced the appointment of a new chief scientific officer. 16 February 2016
Pharmaceutical
The UK's Association of the British Pharmaceutical Industry (ABPI) has named Mike Thompson as its new chief executive. 11 February 2016
Pharmaceutical
US pharma giant Pfizer has named the executive leadership team that will take up the reins after its acquisition of Irish-based Allergan is finalised at the end of this year. 9 February 2016
Pharmaceutical
Astellas Pharma has announced the promotion of James Robinson as president, Americas operations, for Astellas US, with responsibility for the company's operations in North and South America, effective April 1, 2016. 8 February 2016
Biotechnology
Privately-held Swiss biotech firm MaxiVAX SA has appointed Dimitrios Goundis as its chief executive. Dr Goundis joins the company after holding several senior management and R&D positions at The Medicines Company, Speedel and Roche, both in Europe and the USA. 8 February 2016
Pharmaceutical
French drug major Sanofi on Friday named Muzammil Mansuri executive vice president, strategy & business development, effective February 22, 2016. 5 February 2016
Pharmaceutical
Stallergenes Greer has appointed Tibor Nemes as global head of technical operations. 2 February 2016
Biotechnology
Gilead Sciences Inc on Friday said chief operating officer John Milligan will be promoted to chief executive, replacing the current chairman and CEO John Martin who will take on the role of executive chairman, both effective March 10, 2016. 29 January 2016
Pharmaceutical
Swiss pharma major Novartis, along with its financial results (see separate story) this morning, announced a major changes for its underperforming ophthalmic business Alcon, as well as some senior management appointments. 27 January 2016
Pharmaceutical
Germany’s Merck on Wednesday announced two appointments to head its businesses in North America and China in a bid to strengthen its position in the regions. 27 January 2016
Biotechnology
UK-based life sciences company Avacta has appointed Philippe Cotrel as chief commercial officer, the company said in an announcement. 26 January 2016
Pharmaceutical
Valeant Pharmaceuticals’ chief executive Michael Pearson has said he is on the road to recovery but that he was uncertain about when he would return from medical leave. 26 January 2016
Biotechnology
Privately-held US biotech firm Agilis Biotherapeutics has appointed Christopher Silber as its chief medical officer. 26 January 2016
Pharmaceutical
Germany's Merck KGaA said it has appointed Jessie English as the vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. 21 January 2016
Biotechnology
Austria-based biotechnology company Themis Bioscience on Tuesday announced the appointment of two new members to leadership roles, Philippe Dro and Christian Mandl. 19 January 2016
Biotechnology
UK biotech firm Centauri Therapeutics said today it has acquired the Alphamer technology for drug discovery and development from Altermune Technologies. 18 January 2016
Pharmaceutical
Swedish Orphan Biovitrum today announced that Birgitte Volck, senior vice president of development and chief medical officer (CMO) of Sobi, will leave the company. 14 January 2016
Biotechnology
Shares in US biotech firm Celgene Corp closed down over 5.5% on Nasdaq Monday after the company named chief operating officer Mark Alles as chief executive effective March 1, and cut its outlook for 2015. 12 January 2016
Pharmaceutical
Switzerland-based Cardiorentis AG said it has raised 60 million Swiss Franc ($60 million) via private investors to advance its Phase III trials for Ularitide, a therapy for acute decompensated heart failure (ADHF), including upcoming regulatory submissions expected in the second half of 2016. 11 January 2016
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze